LLY

844.3

+3.37%↑

UNH

536.45

-2.05%↓

JNJ

153.76

-0.09%↓

ABBV

191.74

+0.9%↑

NVO

86.61

+4.29%↑

LLY

844.3

+3.37%↑

UNH

536.45

-2.05%↓

JNJ

153.76

-0.09%↓

ABBV

191.74

+0.9%↑

NVO

86.61

+4.29%↑

LLY

844.3

+3.37%↑

UNH

536.45

-2.05%↓

JNJ

153.76

-0.09%↓

ABBV

191.74

+0.9%↑

NVO

86.61

+4.29%↑

LLY

844.3

+3.37%↑

UNH

536.45

-2.05%↓

JNJ

153.76

-0.09%↓

ABBV

191.74

+0.9%↑

NVO

86.61

+4.29%↑

LLY

844.3

+3.37%↑

UNH

536.45

-2.05%↓

JNJ

153.76

-0.09%↓

ABBV

191.74

+0.9%↑

NVO

86.61

+4.29%↑

Search

Abbott Laboratories

Abierto

Sector Salud

127.56 -0.58

Resumen

Variación precio

24h

Actual

Mínimo

126.21

Máximo

128.92

Métricas clave

By Trading Economics

Ingresos

7.6B

9.2B

Ventas

370M

11B

P/B

Media del Sector

34.291

59.362

BPA

1.34

Rentabilidad por dividendo

2.087

Margen de beneficio

84.129

EBITDA

265M

2.7B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+6.99 upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

2.09%

2.35%

Próximas Ganancias

16 abr 2025

Fecha Próximo Dividendo

14 feb 2025

Próxima Fecha de Ex Dividendo

11 abr 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

221B

Apertura anterior

128.14

Cierre anterior

127.56

Noticias sobre sentimiento de mercado

By Acuity

49%

51%

157 / 393 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Abbott Laboratories Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

22 ene 2025, 19:03 UTC

Ganancias

Correction to Abbott Labs 4Q Sales Just Miss Estimates Article

22 ene 2025, 18:20 UTC

Ganancias

Abbott Labs 4Q Sales Just Miss Estimates; Shares Rise on 2025 Outlook -- Update

22 ene 2025, 12:45 UTC

Ganancias

Abbott Labs 4Q Sales Underwhelm Amid Diminished Demand for Covid-19 Related Sales

1 nov 2024, 14:15 UTC

Principales Movimientos del Mercado

Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win -- Update

1 nov 2024, 10:10 UTC

Principales Movimientos del Mercado

Reckitt Shares Surge After Baby Formula Lawsuit Win

31 oct 2024, 23:57 UTC

Acciones populares

Stocks to Watch: Intel, Amazon.com, Abbott Laboratories, MasTec

31 oct 2024, 23:14 UTC

Principales Movimientos del Mercado

Abbott Laboratories Shares Rise After Baby-Formula Verdict

16 oct 2024, 12:03 UTC

Ganancias

Abbott Laboratories 3Q Sales Top Expectations

1 feb 2025, 18:14 UTC

Principales Noticias

Musk's X Adds Nestlé, Colgate, Shell, Other Brands to Ad-Boycott Suit -- WSJ

22 ene 2025, 16:40 UTC

Principales Noticias
Ganancias

Abbott Laboratories Stock Turns Positive. What to Know From Its Earnings. -- Barrons.com

22 ene 2025, 15:20 UTC

Ganancias

Abbott Laboratories Posts 'Middling' Quarter, But Diabetes Devices Shine -- IBD

22 ene 2025, 15:08 UTC

Ganancias

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates -- Barrons.com

22 ene 2025, 13:51 UTC

Ganancias

Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit -- IBD

22 ene 2025, 13:39 UTC

Principales Noticias
Ganancias

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates -- Barrons.com

22 ene 2025, 12:02 UTC

Ganancias

Abbott Labs Sees 1Q Adj EPS $1.05-Adj EPS $1.09 >ABT

22 ene 2025, 12:01 UTC

Ganancias

Abbott Labs Sees 2025 Adj EPS $5.05-Adj EPS $5.25 >ABT

22 ene 2025, 12:01 UTC

Ganancias

Abbott Labs Sees 2025 Adjusted Operating Margin 23.5%-24% >ABT

22 ene 2025, 12:00 UTC

Ganancias

Abbott Labs Sees 2025 Organic Sales Growth 7.5%-8.5% >ABT

22 ene 2025, 12:00 UTC

Ganancias

Abbott Labs 4Q Net $9.23B >ABT

22 ene 2025, 12:00 UTC

Ganancias

Abbott Labs 4Q Sales $10.97B >ABT

22 ene 2025, 12:00 UTC

Ganancias

Abbott Labs 4Q Organic Sales Growth Up 8.8% >ABT

22 ene 2025, 12:00 UTC

Ganancias

Abbott Labs 4Q EPS $5.27 >ABT

22 ene 2025, 12:00 UTC

Ganancias

Abbott Labs 4Q Adj EPS $1.34 >ABT

22 ene 2025, 09:54 UTC

Acciones populares

Stocks to Watch Wednesday: Netflix, Oracle, Trump Media, Softbank -- WSJ

1 nov 2024, 17:33 UTC

Charlas de Mercado

Abbott's Baby-Formula Lawsuit Win Could Decrease Liabilities -- Market Talk

16 oct 2024, 14:21 UTC

Principales Noticias
Ganancias

Abbott Posts Solid Quarter. The Stock Is Rising. -- Barrons.com

16 oct 2024, 12:25 UTC

Ganancias

Abbott Labs Beats Q3 Sales And Earnings Expectations, Raises Full-Year Outlook -- MarketWatch

16 oct 2024, 12:02 UTC

Principales Noticias
Ganancias

Abbott Posts Solid Quarter. That Wasn't Enough to Lift Shares. -- Barrons.com

16 oct 2024, 11:59 UTC

Ganancias

Abbott Earnings Edge Past Q3 Views, Led By Medical Devices -- IBD

16 oct 2024, 11:37 UTC

Ganancias

Abbott Labs Sees 4Q Adj EPS $1.31-Adj EPS $1.37 >ABT

Comparación entre iguales

Cambio de precio

Abbott Laboratories Esperado

Precio Objetivo

By TipRanks

6.99% repunte

Estimación a 12 meses

Media 137.43 USD  6.99%

Máximo 158 USD

Mínimo 117 USD

De acuerdo con 15 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Abbott Laboratories Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

15 ratings

13

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

127.39 / 129.43Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Very Strong Bullish Evidence

Largo Plazo

Neutral Evidence

Sentimiento

By Acuity

157 / 393 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Abbott Laboratories

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.